Understanding acne in transgender individuals
Official title: Epidemiology, impact, and experience of acne in transgender persons
Funded at Emory University · NIH-10898586 · Data updated 2026-11-12
This study is looking at how acne affects transgender people, especially those on hormone therapy, to learn more about how common and serious acne is for them and how it impacts their mental health and daily life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | August 20, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $157,788 |
| NIH project number | 5K23AR075888-05 |
| Project ID | NIH-10898586 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are transgender individuals aged 21 and older who experience acne and are undergoing or have undergone hormone therapy.
✕Less likely to help
Patients who do not identify as transgender or those who do not have acne may not benefit from this research.
What this research studies
This research investigates how acne affects transgender persons, particularly focusing on those undergoing hormone therapy. It aims to understand the prevalence and severity of acne in this population, as well as the impact it has on their mental health and quality of life. The study will utilize data from a large-scale existing study and will involve collecting new information through interviews and surveys to better understand the experiences and treatment barriers faced by transgender individuals with acne.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and support for transgender individuals suffering from acne.
How similar studies have gone: Previous studies have indicated a higher prevalence of acne in transgender individuals undergoing hormone therapy, suggesting that this research builds on existing knowledge rather than being entirely novel.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Yeung, Howa — Emory University
- Study coordinator: Yeung, Howa
Related research
Other NIH-funded projects on the same topics.
-
Acne: how skin oils, bacteria, and the immune system interact
A UC system grant is exploring how acne develops by looking at skin oils, skin bacteria, and the body’s immune response to help find new ways to prevent or treat acne.
-
Acne: how skin bacteria, fats, and immunity drive lesions
A large NIH-funded effort at UCLA/UCSD is studying how skin bacteria, fat metabolism, and the immune system interact to cause acne, with plans to translate findings into better treatments.
-
Spironolactone vs doxycycline for acne in women
A multi-center trial compares spironolactone and doxycycline to treat acne in adult women to find which works better with fewer side effects.
-
Novel endolysins to target Cutibacterium acnes for acne treatment
A small research grant is developing a highly specific enzyme therapy to kill the acne-causing bacteria without disturbing good skin or gut bacteria.
-
Th17 extracellular traps and skin bacteria in acne health
A study in people with acne aims to understand how specific skin bacteria and immune cells interact to fight acne-causing germs and how this could lead to better treatments.
-
New bacteria-targeting enzymes to fight acne
Developing species-specific enzymes to remove the acne-causing bacterium Cutibacterium acnes for people with acne.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.